Literature DB >> 20084090

Sample Sizes Required to Detect Interactions between Two Binary Fixed-Effects in a Mixed-Effects Linear Regression Model.

Andrew C Leon1, Moonseong Heo.   

Abstract

Mixed-effects linear regression models have become more widely used for analysis of repeatedly measured outcomes in clinical trials over the past decade. There are formulae and tables for estimating sample sizes required to detect the main effects of treatment and the treatment by time interactions for those models. A formula is proposed to estimate the sample size required to detect an interaction between two binary variables in a factorial design with repeated measures of a continuous outcome. The formula is based, in part, on the fact that the variance of an interaction is fourfold that of the main effect. A simulation study examines the statistical power associated with the resulting sample sizes in a mixed-effects linear regression model with a random intercept. The simulation varies the magnitude (Δ) of the standardized main effects and interactions, the intraclass correlation coefficient (ρ ), and the number (k) of repeated measures within-subject. The results of the simulation study verify that the sample size required to detect a 2 × 2 interaction in a mixed-effects linear regression model is fourfold that to detect a main effect of the same magnitude.

Entities:  

Year:  2009        PMID: 20084090      PMCID: PMC2678722          DOI: 10.1016/j.csda.2008.06.010

Source DB:  PubMed          Journal:  Comput Stat Data Anal        ISSN: 0167-9473            Impact factor:   1.681


  7 in total

Review 1.  Mediators and moderators of treatment effects in randomized clinical trials.

Authors:  Helena Chmura Kraemer; G Terence Wilson; Christopher G Fairburn; W Stewart Agras
Journal:  Arch Gen Psychiatry       Date:  2002-10

2.  Sample size formulae for intervention studies with the cluster as unit of randomization.

Authors:  F Y Hsieh
Journal:  Stat Med       Date:  1988-11       Impact factor: 2.373

3.  Estimating sample sizes for repeated measurement designs.

Authors:  J E Overall; S R Doyle
Journal:  Control Clin Trials       Date:  1994-04

4.  Randomization by cluster. Sample size requirements and analysis.

Authors:  A Donner; N Birkett; C Buck
Journal:  Am J Epidemiol       Date:  1981-12       Impact factor: 4.897

5.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

6.  Effects of study duration, frequency of observation, and sample size on power in studies of group differences in polynomial change.

Authors:  S W Raudenbush; L Xiao-Feng
Journal:  Psychol Methods       Date:  2001-12

7.  The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.

Authors:  A John Rush; Madhukar H Trivedi; Hicham M Ibrahim; Thomas J Carmody; Bruce Arnow; Daniel N Klein; John C Markowitz; Philip T Ninan; Susan Kornstein; Rachel Manber; Michael E Thase; James H Kocsis; Martin B Keller
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

  7 in total
  38 in total

1.  Testing the universality of the effects of the communities that care prevention system for preventing adolescent drug use and delinquency.

Authors:  Sabrina Oesterle; J David Hawkins; Abigail A Fagan; Robert D Abbott; Richard F Catalano
Journal:  Prev Sci       Date:  2010-12

2.  Undetectable = Untransmittable and Your Health: The Personal Benefits of Early and Continuous Therapy for HIV Infection.

Authors:  Mark J Siedner; Virginia Triant
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

3.  Frontal Brain Asymmetry and the Trajectory of Shyness Across the Early School Years.

Authors:  Kristie L Poole; Diane L Santesso; Ryan J Van Lieshout; Louis A Schmidt
Journal:  J Abnorm Child Psychol       Date:  2019-07

4.  Genetic heterogeneity of Alzheimer's disease in subjects with and without hypertension.

Authors:  Alireza Nazarian; Konstantin G Arbeev; Arseniy P Yashkin; Alexander M Kulminski
Journal:  Geroscience       Date:  2019-05-05       Impact factor: 7.713

5.  Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.

Authors:  M L O Shea; L D Garfield; S Teitelbaum; R Civitelli; B H Mulsant; C F Reynolds; D Dixon; P Doré; E J Lenze
Journal:  Osteoporos Int       Date:  2013-01-29       Impact factor: 4.507

6.  Reporting of Sex Effects by Systematic Reviews on Interventions for Depression, Diabetes, and Chronic Pain.

Authors:  Wei Duan-Porter; Karen M Goldstein; Jennifer R McDuffie; Jaime M Hughes; Megan E B Clowse; Ruth S Klap; Varsha Masilamani; Nancy M Allen LaPointe; Avishek Nagi; Jennifer M Gierisch; John W Williams
Journal:  Ann Intern Med       Date:  2016-04-26       Impact factor: 25.391

7.  Challenge and Yield of Enrolling Racially and Ethnically Diverse Patient Populations in Low Event Rate Clinical Trials.

Authors:  Alice J Sheffet; George Howard; Albert Sam; Zafar Jamil; Fred Weaver; David Chiu; Jenifer H Voeks; Virginia J Howard; Susan E Hughes; Linda Flaxman; Mary E Longbottom; Thomas G Brott
Journal:  Stroke       Date:  2017-11-30       Impact factor: 7.914

8.  Premenopausal gynecologic surgery and survival among black and white women with breast cancer.

Authors:  Mya L Roberson; Hazel B Nichols; Andrew F Olshan; Melissa A Troester; Whitney R Robinson
Journal:  Cancer Causes Control       Date:  2019-12-11       Impact factor: 2.506

9.  Sample size requirements to detect a two- or three-way interaction in longitudinal cluster randomized clinical trials with second-level randomization.

Authors:  Moonseong Heo; Xiaonan Xue; Mimi Y Kim
Journal:  Clin Trials       Date:  2014-05-16       Impact factor: 2.486

10.  The impact of sex on gene expression across human tissues.

Authors:  Meritxell Oliva; Manuel Muñoz-Aguirre; Sarah Kim-Hellmuth; Valentin Wucher; Ariel D H Gewirtz; Daniel J Cotter; Princy Parsana; Silva Kasela; Brunilda Balliu; Ana Viñuela; Stephane E Castel; Pejman Mohammadi; François Aguet; Yuxin Zou; Ekaterina A Khramtsova; Andrew D Skol; Diego Garrido-Martín; Ferran Reverter; Andrew Brown; Patrick Evans; Eric R Gamazon; Anthony Payne; Rodrigo Bonazzola; Alvaro N Barbeira; Andrew R Hamel; Angel Martinez-Perez; José Manuel Soria; Brandon L Pierce; Matthew Stephens; Eleazar Eskin; Emmanouil T Dermitzakis; Ayellet V Segrè; Hae Kyung Im; Barbara E Engelhardt; Kristin G Ardlie; Stephen B Montgomery; Alexis J Battle; Tuuli Lappalainen; Roderic Guigó; Barbara E Stranger
Journal:  Science       Date:  2020-09-11       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.